Navigation Links
China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
Date:11/11/2008

CHINA-BIOTICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts expressed in US Dollars)

September 30, March 31,

2008 2008

ASSETS (unaudited)

Current assets

Cash and cash equivalents $65,633,495 $64,310,448

Accounts receivable 10,447,251 13,214,531

Other receivables 243,497 238,835

Inventories 765,640 408,358

Prepayment 1,828,612 1,806,605

Total current assets $78,918,495 $79,978,777

Property, plant and equipment

and land use right 27,309,641 13,812,749

Total assets $106,228,136 $93,791,526

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

Accounts payable $3,448,485 $2,786,180

Tax payables 24,094,685 22,317,982

Other payables and accruals 2,127,050 1,792,156

Total current liabilities $29,670,220 $26,896,318

Non-current liabilities

Convertible note, with embedded

derivatives of $5,087,000, net

of discount of $7,341,762 as of

September 30, 2008 $22,745,238 $22,197,635

Interest payable 740,628 302,306

Total non-current liabilities $23,485,866 $22,499,941

Commitments and contingencies

Stockholders' equity:

Common stock (par value of $0.0001,

100,000,000 shares authoriz
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
(Date:5/20/2015)... This year has been one of ... US Patented Pearl’s Premium Ultra Low Maintenance Lawn Seed ... that are coming out of record bad weather. ... major global concerns related to water, health, and climate ... alternative to the standard, water-wasting, chemical-treated standard lawn. ...
(Date:5/20/2015)...  Health eCareers, the healthcare industry,s online career ... seekers looking for the flexibility of short-term assignments ... online tool dedicated exclusively to temporary and shift ... enables employers to quickly find and hire experienced ... and other temporary positions, eliminating the time and ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... of oxide compounds, and on its own ... thin and physically stretch it, and then it takes ... to new Cornell research. ( Nature , Aug. 19, ... europium titanate become both ferroelectric (electrically polarized) and ferromagnetic ...
... Corporation (Nasdaq: SIAL ) is pleased to ... and Chief Information Officer, effective August 16, 2010. In ... information systems function and will report to Rakesh Sachdev, ... Officer. Borg (age 50) brings over two ...
... Agreement With IMI Expanding its Presence in... -- JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010, ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Biology Technology:Researchers 'stretch' a lackluster material into a possible electronics revolution 2Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO) 2Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 2Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 3Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 4Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 5Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 6Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 7
(Date:5/22/2015)... 22, 2015 According to a ... (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), by ... Utilities, Consumer and Home) - Global Forecast to 2020", ... $2.77 Billion in 2015 to $6.19 Billion by 2020, ... 79 market data Tables and   43 Figures spread ...
(Date:5/21/2015)... -- The Sync Project™ , a global collaboration ... announced a collaborative partnership with Berklee,s Institute for ... collaboration on original research, joint course development and an ... The Sync Project and BerkleeICE are exploring the launch ... 2015-2016 academic year.  The course will ...
(Date:5/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... owned subsidiary, 3D-ID LLC, a company engaged in biometric ... the biometrics technology portion of the recently awarded TIES ... Department of the Army. 3D-ID LLC has ... government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... insurance are healthier and more engaged in school than ... School of Medicine of the University of Southern California ... a direct health benefit to children from what primary ... care that is accessible, continuous, comprehensive, coordinated, family-centered, compassionate ...
... of the holy grails in diabetes research is to discover ... that target these molecules. Now, JDRF-funded researchers in collaboration with ... only a protein that regulates beta cell growth, but also ... the September 7 issue of Cell Metabolism. ...
... Neurosurgery researchers at UC Davis Health System have used ... of bone tissue following the removal of cervical discs ... to relieve chronic, debilitating pain. The procedure was performed ... It used bone marrow-derived adult stem cells to promote the ...
Cached Biology News:Medical homes linked to better health, school performance 2Medical homes linked to better health, school performance 3Researchers identify new drug target that stimulates 2UC Davis neurosurgeons use adult stem cells to grow neck vertebrae 2UC Davis neurosurgeons use adult stem cells to grow neck vertebrae 3
... Polyclonal Phosphorylated Anti-GluR1 Glutamate is the ... many years it had been considered to ... NMDA, AMPA and kainate receptors that are ... Recently, glutamate has been shown to regulate ...
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
TNF-Related Apoptosis Inducing Ligand-Receptor-1...
Pim-1 (12H8)...
Biology Products: